Another study of diabetic vascular complications hinted at an irisin’s inhibitory effect on ROS-NLRP3 inflammasome signaling; this action occurs through the mitigation of advanced glycation end products-induced inflammation (Deng et al., 2018). Here, FNDC5 is linked to complication.